A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia

Blood

Volumn 88, Issue 6, 1996, Pages 2201-2209

  Munker, Reinhold ^a   Kobayashi, Tohru ^b   Elstner, Elena ^b   Norman, Anthony W ^b   Uskokovic, Milan ^b   Zhang, Wei ^b   Andreeff, Michael ^b   Koeffler, H Phillip ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL DERIVATIVE; CD11B ANTIGEN; CD14 ANTIGEN; CD38 ANTIGEN; CYCLIN DEPENDENT KINASE; HLA DR ANTIGEN; MICROSOMAL AMINOPEPTIDASE; PROTEIN KINASE INHIBITOR; VITAMIN RECEPTOR;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DOSE RESPONSE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL;

EID: 0029823976     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.6.2201.bloodjournal8862201     Document Type: Article

References (52)

1. Reichel H, Koeffler HP, Norman AW:The role of the vitamin D endocrine system in health and disease. N Engl J Med 320:980, 1988
2. Bouillon R, Okamura WH, Norman AW: Structure-function relationships in the vitamin D endocrine system. Endocr Rev 16:200, 1995
3. Studzinski GP, McLane JA, Uskokovic MR: Signaling pathways for vitamin D induced differentiation: Implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Exp 3:279, 1993
4. Munker R, Norman A, Koeffler HP: Vitamin D compounds. Effects on clonal proliferation and differentiation of human myeloid cells. J Clin Invest 78:424, 1986
5. 3 and its fluorinated analogs. Cancer Res 44:5624, 1984
6. 3 is a potent antileukemic agent with low potential to cause hyper-calcemia. Leuk Res 18:453, 1994
7. 3: An extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood 84:1960, 1994
8. 3: Differential effects on leukemic cell growth, differentiation, and intestinal calcium absorption. Cancer Res 50:6857, 1990
9. 3 prolongs survival of leukemic mice. Proc Natl Acad Sci USA 87: 3929, 1990
10. 3 analogs: Effect on leukemic clonal growth, differentiation and serum calcium Leuk Res 19:65, 1995
11. 3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 282:164, 1990
12. 3 analogues: A novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42:1569, 1991
13. 3: Preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. Proc Natl Acad Sci USA 84:2610, 1987
14. 3 with an oxygen atom in the side chain skeleton. A trial of the development of vitamin D compounds which exhibit potent differentiation-inducing activity without inducing hypercalcemia. FEBS Lett 226:58, 1987
15. Binderup L, Bramm E: Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37:887, 1988
16. 3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 78:75, 1991
17. Zhou JY, Norman AW, Lübbert M, Collins ED, Uskokovic MR, Koeffler HP: Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone calcium mobilization. Blood 74:82, 1989
18. 3: In vivo and in vitro effects on human preleukemic and leukemic cells. Cancer Treat Rep 69:1399, 1985
19. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AN, Mercer WP: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55:668, 1995
20. 3 in a single two milliliter plasma sample. J Miner Electr Metab 3:181, 1980
21. 3 to its chick intestinal mucosa receptor using a hydroxyapatite batch assay. Methods Enzymol 67:488, 1980
22. 3. Arch Biochem Biophys 251:222, 1986
23. 1 cyclins. Cell 73:1059, 1990
24. Hirama T, Koeffler HP: Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood 86:841, 1995
25. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature (Lond) 366:701, 1993
26. Bretting C, Hansen CM, Anderson NR: Chemistry and biology of 22,23-yne analogs of calcitriol, in Norman AW, Bouillon R, Thomasset M (eds): Vitamin D, a Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications. Berlin, Germany, de Gruyter, 1994, p 73
27. Campbell MJ, Hirama T, Elstner E, Holden S, Norman AW, Uskokovic, Koeffler HP: 19-nor-hexafluoride analogs of vitamin D, are potent inhibitors of in vitro clonal proliferation of prostate cancer cells: PC-3, DU-145 and LNCaP. (submitted)
28. 3 by human pulmonary macrophages. Biochem Biophys Res Commun 127:596, 1985
29. 3 by interferon gamma stimulated normal human and alveolar bone marrow macrophages. J Biol Chem 262:10931, 1987
30. 3 (as a 6-s-cis analogs) stimulates nongenomic but not genomic biological responses. J Biol Chem 268:13811, 1993
31. 3 Endocrinology 115:1476, 1984
32. 3 in basal lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem 269:23750, 1994
33. 3 receptor-mediated and calcium entry-stimulating pathways in target cells. Am J Physiol 265:F705, 1993
34. 3 analog structure-function assessment of intestinal nuclear receptor occupance with induction of calbindin-D28K. Endocrinology 136:1145, 1995
35. 3 analogs. J Biol Chem 262:4164, 1987
36. 3. Chem Pharm Bull (Tokyo) 35:4362, 1987
37. Ikekawa N: Chemical synthesis of vitamin D analogs with selective biological activities, in Norman AW, Schaefer K, Grigoleit HG, v Herrath D (eds): Vitamin D: Molecular, Cellular and Clinical Endocrinology. Berlin, Germany, de Gruyter, 1991, p 25
38. 3: preferential activity in inducing differentiation of human leukemia cells HL-60 in vitro. Proc Natl Acad Sci USA 84:2610, 1987
39. 3 compounds: Separation of calcium and cell differentiation activities. Biochemistry 29:190, 1990
40. 3 on bone and intestine in vitro. J Pharm Exp 229:9, 1984
41. 3. J. Steroid Biochem Mol Biol 41:109, 1992
42. Inaba M, Okuno S, Nishizawa Y, Yukioko K, Otani S, Matsui-Yuasa I, Morisawa S, DeLuca HF, Morii H: Biological activity of fluorinated vitamin D analogs at C-26 and C-27 on human promyelocytic leukemia cells, HL-60. Arch Biochem Biophys 258:421, 1987
43. 3. J Org Chem 57:4374, 1992
44. Binderup L, Bramm E: Effects of a novel vitamin D analogue MC-903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol 37:889, 1988
45. Binderup L: Immunological properties of vitamin D analogues and metabolites. Biochem Pharmacol 43:1885, 1992
46. 3 analogues: A novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 42:1569, 1991
47. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell, 75:817, 1993
48. Cip1 in muscle and other terminally differentiating cells. Science 267:1024, 1995
49. WAF/1CIP1/SD1I in differentiating human leukemic cells. J Clin Invest 95:973, 1995
50. Akashi M, Hachiya M, Osawa Y, Spirin K, Suzuki G, Koeffler HP: Irradiation induces WAF1 expression through p53-independent pathway in KG-1 cells. J Biol Chem 270:19181, 1995
51. Jung JM, Li H, Kobayashi T, Kyritsis AP, Langford LA, Brunner JM, Levin VA, Zhang W: Inhibition of human glioblastoma cell growth by WAF1/CiP1 can be attenuated by mutant p53. Cell Growth Differ 6:909, 1995
52. Wang QM, Jones JB, Studzinski GP: Cyclin-dependent kinase inhibitor p27 as mediator of the G1-S phase block induced by 1,25-dihydroxyvitamin D3 in HL60 cells. Cancer Res 56:264, 1996